148 related articles for article (PubMed ID: 24803914)
1. Thyroid-stimulating hormone, white matter hyperintensities, and functional outcome in acute ischemic stroke patients.
Leonards CO; Schneider HJ; Liman TG; Fiebach JB; Endres M; Ebinger M
Cerebrovasc Dis Extra; 2014 Jan; 4(1):61-8. PubMed ID: 24803914
[TBL] [Abstract][Full Text] [Related]
2. White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year.
Leonards CO; Ipsen N; Malzahn U; Fiebach JB; Endres M; Ebinger M
Stroke; 2012 Nov; 43(11):3046-51. PubMed ID: 22935398
[TBL] [Abstract][Full Text] [Related]
3. Stroke outcomes are worse with larger leukoaraiosis volumes.
Ryu WS; Woo SH; Schellingerhout D; Jang MU; Park KJ; Hong KS; Jeong SW; Na JY; Cho KH; Kim JT; Kim BJ; Han MK; Lee J; Cha JK; Kim DH; Lee SJ; Ko Y; Cho YJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Park TH; Lee J; Choi HK; Lee K; Bae HJ; Kim DE
Brain; 2017 Jan; 140(1):158-170. PubMed ID: 28008000
[TBL] [Abstract][Full Text] [Related]
4. Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.
Zerna C; Yu AYX; Modi J; Patel SK; Coulter JI; Smith EE; Coutts SB
Stroke; 2018 Apr; 49(4):919-923. PubMed ID: 29540612
[TBL] [Abstract][Full Text] [Related]
5. Brainstem leukoaraiosis independently predicts poor outcome after ischemic stroke.
Giralt-Steinhauer E; Medrano S; Soriano-Tárraga C; Mola-Caminal M; Rasal R; Cuadrado-Godia E; Rodríguez-Campello A; Ois A; Capellades J; Jimenez-Conde J; Roquer J
Eur J Neurol; 2018 Aug; 25(8):1086-1092. PubMed ID: 29660221
[TBL] [Abstract][Full Text] [Related]
6. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort.
Medrano-Martorell S; Capellades J; Jiménez-Conde J; González-Ortiz S; Vilas-González M; Rodríguez-Campello A; Ois Á; Cuadrado-Godia E; Avellaneda C; Fernández I; Merino-Peña E; Roquer J; Martí-Fàbregas J; Giralt-Steinhauer E
Eur Radiol; 2022 Jan; 32(1):272-280. PubMed ID: 34117555
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke.
Zhu S; Qian S; Xu T; Peng H; Dong R; Wang D; Yuan X; Guo L; Zhang Y; Geng D; Zhong C
Stroke; 2020 May; 51(5):1608-1612. PubMed ID: 32233741
[TBL] [Abstract][Full Text] [Related]
8. Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke.
Yu F; Feng X; Li X; Luo Y; Wei M; Zhao T; Xia J
Front Aging Neurosci; 2021; 13():675158. PubMed ID: 34393756
[No Abstract] [Full Text] [Related]
9. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke.
Nagaraja N; Farooqui A; Albayram MS
J Neuroimaging; 2022 Mar; 32(2):268-272. PubMed ID: 34861077
[TBL] [Abstract][Full Text] [Related]
10. Chronic cerebral infarctions and white matter lesions link to long-term survival after a first ischemic event: A cohort study.
Schilter M; Epstein A; Vynckier J; Mujanovic A; Belachew NF; Beyeler M; Siepen B; Goeldlin M; Scutelnic A; Seiffge DJ; Jung S; Gralla J; Dobrocky T; Arnold M; Kaesmacher J; Fischer U; Meinel TR
J Neuroimaging; 2022 Nov; 32(6):1134-1141. PubMed ID: 35922890
[TBL] [Abstract][Full Text] [Related]
11. Fasting versus post-challenge triglycerides and pre-existing cavitating lacunes: a berlin "cream & sugar" substudy.
Leonards CO; Wang L; Fiebach JB; Endres M; Ebinger M
Front Neurol; 2013; 4():92. PubMed ID: 23847590
[TBL] [Abstract][Full Text] [Related]
12. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke.
Wollenweber FA; Zietemann V; Gschwendtner A; Opherk C; Dichgans M
Stroke; 2013 May; 44(5):1446-8. PubMed ID: 23482604
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease.
Park JH; Heo SH; Lee MH; Kwon HS; Kwon SU; Lee JS;
Eur J Neurol; 2019 Jun; 26(6):911-918. PubMed ID: 30637882
[TBL] [Abstract][Full Text] [Related]
14. Low Free Triiodothyronine Predicts 3-Month Poor Outcome After Acute Stroke.
Suda S; Shimoyama T; Nagai K; Arakawa M; Aoki J; Kanamaru T; Suzuki K; Sakamoto Y; Takeshi Y; Matsumoto N; Nishiyama Y; Nito C; Mishina M; Kimura K
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2804-2809. PubMed ID: 30056971
[TBL] [Abstract][Full Text] [Related]
15. Kidney function and white matter disease in young stroke patients: analysis of the stroke in young fabry patients study population.
Steinicke R; Gaertner B; Grittner U; Schmidt W; Dichgans M; Heuschmann PU; Tanislav C; Putaala J; Kaps M; Endres M; Schmidt R; Fazekas F; Norrving B; Rolfs A; Martus P; Tatlisumak T; Enzinger C; Jungehulsing GJ
Stroke; 2012 Sep; 43(9):2382-8. PubMed ID: 22723456
[TBL] [Abstract][Full Text] [Related]
16. Kidney impairment and outcomes in acute ischaemic stroke.
Nagaraja N; Farooqui A; Ballur Narayana Reddy V; Shukla AM
Intern Med J; 2023 Jul; 53(7):1231-1239. PubMed ID: 35717661
[TBL] [Abstract][Full Text] [Related]
17. Association of Plasma Lipids with White Matter Hyperintensities in Patients with Acute Ischemic Stroke.
Liu Y; Yuan C; Chen X; Fang X; Hao J; Zhou M; Sun X; Wu M; Wang Z
Int J Gen Med; 2023; 16():5405-5415. PubMed ID: 38021054
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis.
Baik M; Kim K; Yoo J; Kim HC; Jeong SH; Kim KH; Park HJ; Kim YD; Heo JH; Nam HS
PLoS One; 2017; 12(12):e0189611. PubMed ID: 29232701
[TBL] [Abstract][Full Text] [Related]
19. Ischemic Stroke and Impact of Thyroid Profile at Presentation: A Systematic Review and Meta-analysis of Observational Studies.
Dhital R; Poudel DR; Tachamo N; Gyawali B; Basnet S; Shrestha P; Karmacharya P
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2926-2934. PubMed ID: 28821377
[TBL] [Abstract][Full Text] [Related]
20. Long-term progression of white matter hyperintensities in ischemic stroke.
Holmegaard L; Jensen C; Redfors P; Blomstrand C; Jern C; Jood K
Acta Neurol Scand; 2018 Dec; 138(6):548-556. PubMed ID: 30152523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
